How the LDT Final Rule’s Exemptions Apply to Oncology Labs
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
Dan J. Scungio, MLS (ASCP), SLS, CQA (ASQ), discusses recent developments in lab safety and how to address key challenges.
Lab leaders need to be aware that in some cases, following additional standards such as ANSI may not be voluntary at all.
When it comes to protected health information, it’s important that labs manage contracts with external sources to ensure HIPAA compliance.
The end of the COVID-19 public health emergency on May 11 also brings certain flexibilities for labs and other providers to an end.
It’s imperative for labs to establish and maintain an active corporate compliance program that augments the actual scientific testing.
A new OIG Advisory Opinion sheds some light on how to properly structure these arrangements in a hospital inpatient setting.
Could paying the tuition costs of employees seeking certification put you at risk of violating the AKS?